Health ministry: Sale license exempted for hand sanitizers under D&C Act

The Union health ministry has exempted hand sanitizers from the requirement of sale license under the provisions of Chapter IV of the Drugs and Cosmetics (D&C) Act, 1940 and the provisions of the D&C Rules, 1945 for ensuring the easy availability of hand sanitizers in the interest of public and patient safety.

Several representations have been received requesting to exempt hand sanitizers from the requirement of sale license under the provisions of Chapter IV of the D&C Act, 1940 and the provisions of the D&C Rules, 1945 for stocking or sale of the drug. The Central government considers it necessary that hand sanitizers are required to be made widely available to the public at large, according to the ministry’s notification.

A letter was also sent by the Maharashtra Food and Drug Administration (FDA) to the Central Drugs Standard Control Organisation (CDSCO) to allow exemption of sale license for hand sanitizers. “Exemption of sale license for hand sanitizers will not only make it available but also will offer competitiveness to the manufacturers in producing sanitizers at an affordable price. More so, as there is now no price control on hand sanitizers as the government had capped the maximum retail price (MRP) of hand sanitizer at Rs. 500 per litre bottle till June 30, 2020,” according to a senior FDA official.

An order was notified by the Government under the Essential Commodities (EC) Act for declaring the hand sanitizers as essential commodities up to June 30, 2020 by amending provisions of EC Act, 1955. An advisory was issued under the Legal Metrology (LM) Act. States could ask manufacturers to enhance production capacity of hand sanitizers, for making the supply smooth, while under the LM Act, the States could ensure sale of both the items at maximum retail price, as per the ministry’s notification.

Source: Pharmabiz

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    Six fake doctors arrested in Hyderabad

    Six fake doctors arrested in Hyderabad